I-125 seed planning: An alternative method of urethra definition

Radiotherapy and Oncology

Volumn 94, Issue 1, 2010, Pages 24-29

  Anderson, Clare ^a   Lowe, Gerry ^a   Ostler, Peter ^a   Inchley, David ^a   Hardiman, Claire ^a   Wills, Rachel ^a   Bryant, Linda ^a   Chapman, Caroline ^a   Marchant, Neal ^a   Hoskin, Peter J ^a  

^a MOUNT VERNON CANCER CENTRE   (United Kingdom)

Author keywords

Brachytherapy; I 125; Prostate cancer; Seed implant; Urethra

Indexed keywords

IODINE 125;

ARTICLE; CATHETER; CLINICAL ARTICLE; CONTROLLED STUDY; DOSIMETRY; GEL; HUMAN; IMPLANT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCRIPTION; PRIORITY JOURNAL; PROSTATE; TREATMENT PLANNING; URETHRA;

BRACHYTHERAPY; HUMANS; MALE; ORGAN SIZE; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; URETHRA;

EID: 74549171597     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.11.003     Document Type: Article

References (17)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics 2007. CA Cancer J Clin 57 (2007) 43-66
2. Parkin D.M., Bray F., Ferley J., et al. Global cancer statistics. CA Cancer J Clin 55 (2005) 74-108
3. Sloboda R., and Pedersen J. The importance of urethral visualization for preplanned permanent prostate implants. Brachytherapy 4 (1995) 195-201
4. Salembier C., Lavagnini P., Nickers P., et al. Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy. Radiother Oncol 83 (2007) 3-10
5. Wallner K., Roy J., and Harrison M. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys 32 (1995) 465-471
6. Merrick G., Butler W., Tollenaar B., et al. The dosimetry of prostate brachytherapy-induced urethral strictures. Int J Radiat Oncol Biol Phys 52 (2002) 461-468
7. Rivard M.J., Coursey B.M., DeWerd L.A., et al. Update of AAPM Task Group No. 43 Report: a revised AAPM protocol for brachytherapy dose calculations. Med Phys 31 (2004) 633-674
8. Baltas D., Kolotas C., Geramani K., et al. A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy. Int J Radiat Oncol Biol Phys 40 (1998) 515-524
9. ICRU Report No. 50. Prescribing, recording and reporting photon beam therapy; 1993.
10. ICRU Report No. 62. A supplement to ICRU 50; 1999.
11. Mitchell D., Mandall P., Bottomley D., et al. Report on the early efficacy and tolerability of I-125 permanent prostate brachytherapy from a UK multi-institutional database. Clin Oncol 20 (2008) 738-744
12. Dogan N., Mohideen N., Glasgow G., et al. Effect of prostatic edema on CT-based postimplant dosimetry. Int J Radiat Oncol Biol Phys 53 (2002) 483-489
13. Roberson P., Narayana V., McShan D., et al. Source placement error for permanent implant of the prostate. Med Phys 24 (1997) 251-257
14. Al-Qaisieh B. Pre- and post-implant dosimetry: an intercomparison between UK prostate brachytherapy centres. Radiother Oncol 66 (2003) 181-183
15. Al-Qaisieh B., Ash D., Bottomley D., et al. Impact of prostate volume evaluation by different observers on CT-based post implant dosimetry. Radiother Oncol 62 (2002) 267-273
16. Tanaka O., Hayashi S., Matsuo M., et al. MRI-based preplanning in low-dose-rate prostate brachytherapy. Radiother Oncol 88 (2008) 115-120
17. Millar J., Longano A., Imbert S., et al. A simple technique for determining accurate urethral dosimetry after seed brachytherapy for prostate cancer. Brachytherapy 5 (2006) 27-31